Explain this page
Arphra AIPlain-English read on Protagonist Therapeutics, Inc.’s valuation06-10today
- Protagonist Therapeutics Reports Granting of Inducement Awards2d
- Protagonist Therapeutics Reports Granting of Inducement Awards2d
- Protagonist Therapeutics: A Royalty-Driven Biotech With Two Shots On Goal5d
- Protagonist Therapeutics, Inc. (PTGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript8d
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $115.40 (+2.87%)
Candlestick · 1Y
Open in chart workstation →PTGX
112.46+35.41%H 112.77L 77.00MA50 100.47MA200 —Avg vol 706K
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.66% | +2.12% | +11.36% | +15.54% | +30.76% | +28.44% | +108.05% | +315.64% | +164.14% | +858.80% | +858.80% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$14.4M
6 txns
Net flow
−$14.4M
Aftermarket
LiveLast trade
$110.64
1 sh
Bid
$111.92
103 sh
Ask
$112.45
100 sh
Spread
$0.530
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Technology+2.53%
- Communication Services+2.28%
- Utilities+0.64%
- Consumer Cyclical+0.47%
- Consumer Defensive-0.32%
- Industrials-0.48%
- Basic Materials-0.64%
- Energy-0.75%
- Real Estate-0.76%
- Financial Services-1.08%
- Healthcare-1.31%
Top industries (issuer's industry highlighted)
- Biotechnology-4.85%
- Business Equipment & Supplies+6.57%
- Electronic Gaming & Multimedia+6.45%
- Other Precious Metals-4.95%
- Semiconductors+4.52%
- Medical - Equipment & Services+4.26%
- Grocery Stores-4.13%
- Oil & Gas Drilling-3.68%
- Internet Content & Information+3.47%
- Financial - Mortgages+3.40%
- Gold-3.28%
- Oil & Gas Equipment & Services-3.15%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Protagonist Therapeutics Reports Granting of Inducement Awardsaccessnewswire.com·Jun 16, 2026
- Protagonist Therapeutics Reports Granting of Inducement Awardsaccessnewswire.com·Jun 16, 2026
- Protagonist Therapeutics: A Royalty-Driven Biotech With Two Shots On Goalseekingalpha.com·Jun 13, 2026
- Protagonist Therapeutics, Inc. (PTGX) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcriptseekingalpha.com·Jun 10, 2026
- Protagonist Reports First Quarter 2026 Financial Results and Provides Corporate Updateaccessnewswire.com·May 05, 2026
Peers
No peer list available for PTGX.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Waddill William D. director | Sell | 9,000 | $969.12K | Jun 10, 2026 |
PATEL DINESH V PH D director, officer: President and CEO | Sell | 75,000 | $7.51M | May 12, 2026 |
Giraudo Bryan director | Sell | 5,130 | $513K | May 08, 2026 |
Giraudo Bryan director | Sell | 6,000 | $600K | May 08, 2026 |
Giraudo Bryan director | Sell | 12,000 | $1.2M | May 07, 2026 |
Giraudo Bryan director | Sell | 36,000 | $3.61M | May 07, 2026 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|